Navigation Links
Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
Date:9/3/2007

its customers in over 125 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 49 countries and manufacturing operations in 11 countries.

* Razadyne(TM) is a registered trademark of Janssen Pharmaceutica Inc.

CONTACTS: Charles M. Caprariello

Vice President, Corporate Communications

Ranbaxy Inc.

(609) 720-5615

Edwige Buteau

RF Binder Partners Inc.

(212) 994-7517

Anuj Baveja

RF Binder Partners Inc.

(212) 994-7552


'/>"/>
SOURCE Ranbaxy Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. RANBAXY - enters anti-AIDS segment
2. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
3. Ranbaxy gets US FDA approval for Lisinopril
4. Ranbaxy Labs Entry Into Anti-Acne Market
5. Ranbaxy trying to make inroads in herbal drugs market
6. Lamivudine Manufactured By Ranbaxy gets the nod from the US FDA
7. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
8. Ranbaxy opens Drug discovery centre in Gurgaon
9. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
10. Ranbaxy Gets USFDA Approval For Doxycycline Tablets
11. SRL Ranbaxy offers quicker bird flu diagnostic test
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 2Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 3Health News:Life Science And Medical Device Software Engineering Consulting Firm Full Spectrum Software Announces 12 New Contract Wins In 2009 2Health News:Unanimous Vote Creates Largest RN Union in U.S. History 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 3Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 4Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 5Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 3Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 4Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 5
Breaking Medicine Technology:Rib-X Pharmaceuticals Expands License Agreement with Yale University on New Ribosome Technology 2Patent Expiries of Blockbuster Antibiotics Will Fuel a Decline of More Than 15 Percent in the Community-Acquired Pneumonia Drug Market 2$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 2$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 3$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 4$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 5$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 6AdCare Health Systems Inc Continues To Be Profitable 3B Reports 2009 Second Quarter Earning Results 54537 1AdCare Health Systems Inc Continues To Be Profitable 3B Reports 2009 Second Quarter Earning Results 54537 2AdCare Health Systems Inc Continues To Be Profitable 3B Reports 2009 Second Quarter Earning Results 54537 3AdCare Health Systems Inc Continues To Be Profitable 3B Reports 2009 Second Quarter Earning Results 54537 4AdCare Health Systems Inc Continues To Be Profitable 3B Reports 2009 Second Quarter Earning Results 54537 5AdCare Health Systems Inc Continues To Be Profitable 3B Reports 2009 Second Quarter Earning Results 54537 6AdCare Health Systems Inc Continues To Be Profitable 3B Reports 2009 Second Quarter Earning Results 54537 7AdCare Health Systems Inc Continues To Be Profitable 3B Reports 2009 Second Quarter Earning Results 54537 8AdCare Health Systems Inc Continues To Be Profitable 3B Reports 2009 Second Quarter Earning Results 54537 9AdCare Health Systems Inc Continues To Be Profitable 3B Reports 2009 Second Quarter Earning Results 54537 10Smart Payment Strategies Enable Growth in Home Health Care and Disease Management Markets for Remote Patient Monitoring Finds Frost 26 Sullivan 54534 1Smart Payment Strategies Enable Growth in Home Health Care and Disease Management Markets for Remote Patient Monitoring Finds Frost 26 Sullivan 54534 2Smart Payment Strategies Enable Growth in Home Health Care and Disease Management Markets for Remote Patient Monitoring Finds Frost 26 Sullivan 54534 3Smart Payment Strategies Enable Growth in Home Health Care and Disease Management Markets for Remote Patient Monitoring Finds Frost 26 Sullivan 54534 4Get Smart About Swine Flu for Back to School 54531 1Get Smart About Swine Flu for Back to School 54531 2Get Smart About Swine Flu for Back to School 54531 3